SGLT2 & GLP-1 in Diabetes

iOS Universel / Medecine

This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.

Quoi de neuf dans la dernière version ?

Updated application to handle screens with notches better.

D'autres applications du développeur

CV Augmented RealityiOS UniverselDiabetic Retinopathy ARiOS UniverselAMD & Anti-VEGF TherapyiOS UniverselDR & PRP TherapyiOS UniverselCovid Frontline ARiOS UniverselFamilial HypercholesterolemiaiOS UniverselVoir toutes les apps